Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti-Müllerian Hormone and Cardiometabolic Disease in Women: A Two-Sample Mendelian Randomization Study

Reviews in Cardiovascular Medicine(2022)10.31083/j.rcm2308269Source: DataRank Database

Anti-Müllerian Hormone and Cardiometabolic Disease in Women: A Two-Sample Mendelian Randomization Study is a research paper published in Reviews in Cardiovascular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.52)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Joanna von Berg ORCID,M. Abdullah Said ORCID,Pim van der Harst ORCID,Anubha Mahajan ORCID,Carla H. van Gils ORCID

Live enrichment

PubMed:39076620 PMC:PMC11266950 OpenAlex:https://openalex.org/W4288729728

Dutch Research Council (NWO)

Grant: 022.005.021

Utrecht University, Graduate School of Life Sciences, PhD programme Epidemiology

National Institutes of Health

Grant: 5R01NS100178-02

Genetics of ischemic stroke in the SiGN Consortium

FWCI

0.52

Citation Percentile

0.7%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308269/pdf

publisherhttps://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308269/pdf

publisherhttps://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308269

journalhttps://doi.org/10.31083/j.rcm2308269

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39076620

Fields of Study

Ovarian function and disordersPituitary Gland Disorders and TreatmentsGenetic Neurodegenerative Diseases03 medical and health sciences0302 clinical medicine

Keywords

Mendelian randomizationMedicineAnti-Müllerian hormoneSingle-nucleotide polymorphismInternal medicineOdds ratioGenome-wide association studyGynecologyBioinformaticsGeneticsHormoneGenotypeType 2 diabetesStrokeWomencoronary artery diseaseAmhRC666-701Diseases of the circulatory (Cardiovascular) systemOriginal Research

Sustainable Development Goals

SDG 0: Good health and well-being

Anti-Müllerian Hormone and Cardiometabolic Disease in Women: A Two-Sample Mendelian Randomization Study

FAIR Checklist

Authors (8)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)